| Margins | Operational performance improvements managed steadily over last 8 years. |
|---|---|
| Demand visibility | Strong hospital service demand; patients unaffected by shareholding legalities. |
| Management confidence | High; confident in legal compliance and operational insulation from court proceedings. |
Growth
No quarterly financial metrics (Revenue/PAT) reported for Q1 FY27; focus remains on long-term India growth engine.
Outlook
IHH committed to increasing stake to 50%+ and integrating Gleneagles; brownfield expansion plans continue as scheduled.
Risks
Potential 6-month forensic audit timeline; legal expenses estimated at approximately INR 25 crores annually.
Earnings Call Transcript filed with BSE, NSE: FORTIS. Summary written with AI assistance from the document.
Fortis Healthcare Ltd: key numbers
- Share price
- ₹837.85
- Market cap
- ₹63,254 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 60.4×Sector 57.8×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 25.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fortis Healthcare Ltd
All →Fortis Healthcare Legal & Regulatory
Northern TK Venture Pte Ltd, Fortis Healthcare's promoter, has appealed a Tokyo District Court judgment to the Tokyo High Court. The litigation concerns losses related to delayed tender offer approvals.
Fortis Healthcare Partnership
Fortis Hospotel signed definitive agreements with SLJ Society to provide healthcare services at their 400+ bed hospital. Fortis will provide a ₹567 Crore loan.
- Value
- ₹567.0 Cr
- From
- Seth Sunder Lal Jain Charitable Eye Hospital (SLJ Society)
- hospital beds
- 400.0 beds
Fortis Healthcare Legal & Regulatory
Tokyo District Court dismissed all NTK claims against Daiichi Sankyo; NTK must bear litigation costs. NTK is reviewing the judgment and evaluating appeal options.
Fortis Healthcare Investor Presentation: Key Takeaways
Fortis Q1FY27 consolidated revenue grew 17.5% YoY to INR 2,545 Cr. Consolidated Operating EBITDA rose 15.8% to INR 568 Cr with a 22.3% margin.
Fortis Healthcare Q1 FY27 Results: Net Profit ₹272.8 Cr, Up 2.2% YoY
Fortis Healthcare Ltd reported revenue from operations of ₹2,545 Cr (+17.5% YoY) and net profit of ₹272.8 Cr (+2.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹272.8 Cr · +2.2% YoY
Fortis Healthcare Earnings Call: Key Takeaways
Fortis reported strong FY26 performance with 17.3% revenue growth and 31.5% PAT growth. Strategy focuses on brownfield expansion and diagnostic margin improvement.